MedPath

Effectiveness and Cost-utility Analysis of Spinal Cord Stimulation for Chronic Intractable Pain in Thailand

Completed
Conditions
Patients undergoing SCS implants due to intractable pain at Siriraj Hospital
spinal cord stimulation
effectiveness
quality-adjusted life year
incremental cost-utility ratios
cost-utility analysis
willingness to pay
Thailand
Registration Number
TCTR20210923001
Lead Sponsor
Mahidol University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria

CMM group
1) The patients were more than 7 years old
2) The patients suffered from chronic intractable pain from FBSS, PVD or neuropathic pain
3) The patients reported no satisfactory response to previous treatment defined by a pain score (numeric rating scale or NRS) of at least 5 out of 10 for at least 2 years, despite physical therapy, appropriate regimen of pain medication (gabapentin dose of more than 900 mg/day or pregabalin more than 150 mg/day and two or more other pain medications), other pain interventions or surgery.

SCS+CMM group
Any patients who underwent a successful SCS trial and subsequent implantation.

Exclusion Criteria

1. Refusal to participate in the study
2. Pain due to cancer 3. Difficulty of communication or poor literacy of Thai language

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cost-utility Post-treatment (3 years time points) incremental cost-utility ratio
Secondary Outcome Measures
NameTimeMethod
Pain score Post-treatment (1-6 months time points) Numeric rating pain score range: 0-10,Overall pain-related interference Post-treatment (1-6 months time points) Brief Pain Inventory questionnaire (range: 0-70),Utility Post-treatment (1-6 months time points) EQ-5D-5L health questionnaires21(Thai version)
© Copyright 2025. All Rights Reserved by MedPath